Genetic chaos in aggressive cancer
11 – 20 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells
(
- Contribution to journal › Article
-
Mark
Loss of NF2 defines a genetic subgroup of non-FOS-rearranged osteoblastoma
(
- Contribution to journal › Article
- 2019
-
Mark
Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion
(
- Contribution to journal › Article
-
Mark
Gene fusion involving the insulin-like growth factor 1 receptor in an ALK-negative inflammatory myofibroblastic tumour
(
- Contribution to journal › Article
- 2017
-
Mark
Loss of the tumor suppressor gene AIP mediates the browning of human brown fat tumors
(
- Contribution to journal › Article
-
Mark
Scattered genomic amplification in dedifferentiated liposarcoma
(
- Contribution to journal › Article
- 2016
-
Mark
PKC activation sensitizes basal-like breast cancer cell lines to Smac mimetics
(
- Contribution to journal › Article
- 2014
-
Mark
Integrative Genome and Transcriptome Analyses Reveal Two Distinct Types of Ring Chromosome in Soft Tissue Sarcomas.
(
- Contribution to journal › Article
-
Mark
GRM1 is upregulated through gene fusion and promoter swapping in chondromyxoid fibroma.
(
- Contribution to journal › Article
- 2013
-
Mark
Recurrent chromosome 22 deletions in osteoblastoma affect inhibitors of the wnt/beta-catenin signaling pathway.
(
- Contribution to journal › Article